← back to search

John L. Johnson

CTS Corporation (United States) · US
Area of research
Infectious Diseases · Astronomy and Astrophysics
Research interest
Research interests include Tuberculosis Research and Epidemiology, Magnetic confinement fusion research, Mycobacterium research and diagnosis, and Ionosphere and magnetosphere dynamics.
h-index
73
citations
20,970
works
626
NIH funding
primary concept
Medicine
email

Recent publications

Differences in Neutrophil Counts Between African and Non-African Countries in 2 International Clinical Trials.
2025cited by 0position: contributordoi
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
2025cited by 0position: contributordoi
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
Nature Communications 2024cited by 26position: middledoi
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
2024cited by 19position: contributordoi
Dual β-lactam for treatment of pulmonary <i>Mycobacterium abscessus</i> in a child.
2024cited by 11position: contributordoi
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
2023cited by 4position: contributordoi
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
European Respiratory Journal 2022cited by 35position: middledoi
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Immunity 2021cited by 703position: middledoi
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
New England Journal of Medicine 2021cited by 542position: middledoi
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
Contemporary Clinical Trials 2020cited by 56position: middledoi
TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision
Immunity 2019cited by 690position: middledoi
MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria.
2019cited by 61position: contributordoi
Distinct serum biosignatures are associated with different tuberculosis treatment outcomes
Tuberculosis 2019cited by 34position: middledoi
Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients
Antimicrobial Agents and Chemotherapy 2019cited by 31position: middledoi
Outcomes of Inpatient Versus Outpatient Elective Foot and Ankle Surgery
Cureus 2019cited by 23position: middledoi
Attitudes and awareness of suture anchor cost: a survey of shoulder surgeons performing rotator cuff repairs
Journal of Shoulder and Elbow Surgery 2019cited by 19position: firstdoi
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
Nature Medicine 2018cited by 374position: middledoi
Is interposition arthroplasty a viable option for treatment of moderate to severe hallux rigidus? — A systematic review and meta-analysis
Foot and Ankle Surgery 2018cited by 23position: middledoi
Risk Factors for Readmission Following Revision Total Hip Arthroplasty in Patients Undergoing Surgery for Noninfective Causes
Cureus 2018cited by 7position: middledoi
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
Nature Medicine 2018cited by 6position: middledoi
Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis
Tuberculosis 2015cited by 34position: middledoi
Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging Trial
American Journal of Respiratory and Critical Care Medicine 2014cited by 112position: middledoi
Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis
Tuberculosis 2014cited by 62position: middledoi
Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment
PLoS ONE 2013cited by 112position: middledoi
The Association between Symptoms and Microbiologically Defined Response to Tuberculosis Treatment
Annals of the American Thoracic Society 2013cited by 26position: middledoi
Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
The Journal of Infectious Diseases 2012cited by 110position: middledoi

Grants

MINERVA: Purchase of Kiwispec, a Robotic Precision Spectrograph to Detect Earth-Like Planets Around Nearby Stars
NSF1608203$1,089,5172016–2020PIRePORTER
MINERVA: A dedicated observatory for exoplanet science
NSF1516242$468,7552015–2019PIRePORTER
Conference on New Studies of Neurobehavioral Evolution; Washington, DC; June 25-28 2010
NSF1023222$20,0002010–2011PIRePORTER
Exploring the Relationship Between Stellar Mass and Planet Occurrence
NSF0702821$139,0002007–2009PIRePORTER
Collaborative Research: Accessing Brain Collection Information and Images Via the Internet, CD-ROM and Centralized Location
NSF0131267$243,8802002–2007PIRePORTER
Colaborative Research: Accessing Brain Collection Informationand Images Via Internet, CD-Rom and Centralized Location
NSF9814911$240,7051998–2003PIRePORTER
Collaborative Research: Accessing Comparative Brain Collections
NSF9528326$54,5071995–1998PIRePORTER
Imaging the Diversity of Mammalian Brains: An Electronic Catalog for Wide Accessibility
NSF9111592$49,9891991–1994PIRePORTER
The Structure and Function of Triocornaviruses
NSF8817057$468,2001989–1994PIRePORTER
Software Development for Macromolecular Crystallography
NSF8509549$617,5001986–1991PIRePORTER
Mammalian Phylogeny Through Brain Traits and DNA Similarities
NSF8503687$275,0001985–1989PIRePORTER
Structural Studies of Multi Component RNA Plant Viruses
NSF8511084$204,8741985–1989PIRePORTER
The Remaining Life in Deteriorated Steel Deck-Girder Highway Bridges
NSF8407248$90,0001984–1987PIRePORTER
Structural Studies of a Multi Component Rna Plant Virus
NSF8207402$138,0001982–1986PIRePORTER
Regional Specializations in Cerebral Cortex
NSF8108073$84,7431981–1984PIRePORTER
Ribosomal Rna Homologies Among Anaerobic Bacteria
NSF8001191$110,0111980–1983PIRePORTER
Structural Studies of a Multicomponent Rna Plant Virus
NSF7911010$166,0001979–1983PIRePORTER
Purchase of Anode Generator
NSF7819039$45,0001979–1980PIRePORTER
Integration of Microprocessors in Physics Curriculum
NSF7900861$11,4131979–1981PIRePORTER
Regional Specializations in Cerebral Neocortex
NSF7800879$90,0001978–1980PIRePORTER
Digital Signal Processing
NSF7813481$2,5001978–1981PIRePORTER

Frequent collaborators

Payam Nahid · Global Brain Health Institute10 papers (2012–2025) · 6 papers (2019–2025)Grace Muzanyi · University Hospitals of Cleveland5 papers (2012–2014)Marc Weiner · Hôpital Beau-Séjour5 papers (2012–2015)Patrick Phillips · Ludwig-Maximilians-Universität München5 papers (2018–2025)Gerald McGwin · University of Alabama at Birmingham3 papers (2018–2019)Andrew Vernon · Centers for Disease Control and Prevention3 papers (2012–2014)Richard E. Chaisson · Alexandra Hospital3 papers (2013–2025)Ashish Shah · University of Miami3 papers (2018–2019)Charles M. Heilig · Centers for Disease Control and Prevention3 papers (2012–2014) · 3 papers (2023–2025)Radojka M. Savić · Global Brain Health Institute3 papers (2014–2025)Stefan Goldberg · Centers for Disease Control and Prevention3 papers (2012–2014)Sameer Naranje · University of Alabama at Birmingham3 papers (2018–2019)Samuel Huntley · University of Miami3 papers (2018–2019)Christian Lienhardt · Inserm2 papers (2018–2018) · 2 papers (2012–2014)Harshadkumar A. Patel · Westchester Medical Center2 papers (2018–2018) · 2 papers (2014–2015)Melissa Engle · The University of Texas Health Science Center at San Antonio2 papers (2014–2015)